Publication #1277

Reference
Name
Review of the utility of the pain reliever co-proxamol (distalgesic; cosalgesic; dolgesic) and request for evidence on risks and benefits
Categories
Scottish Government
Organization
Medicines & Healthcare products
Keywords
NHS SCOTLAND PAIN RELIEF ANALGESICS TREATMENT DRUG THERAPY EFFECTIVENESS RISKS SAFETY MORTALITY
Description
The Medicines and Healthcare products Regulatory Agency (MHRA) is currently conducting a review of the risks and benefits of co-proxamol, in the light of longstanding concerns about safety and efficacy and more recent data concerning safety in overdose.

This letter seeks further available information relevant to the review.

Contact Name
Contact Email
Contact Address
Contact Phone

Created
2004-06-30 00:00:00


Click to go back to homepage